After the Indian government promoted the use of ivermectin and hydroxychloroquine, cases of the Chinese communist virus plummeted, and the elite were worried.

The Gateway Pundit reported on May 17 that according to the India Ministry of Health and Family Welfare, there were 3.6 million active cases of CCHV in India in April of this year, yet by the end of April, the number of CCHV cases in India began to drop sharply. This is thanks to the Indian Ministry of Health’s April 28 update of its CCHV guidelines, which promote the use of Ivermectin and hydroxychloroquine to a large number of Indians.

The agency recommends that asymptomatic people and patients with mild symptoms “consider ivermectin (200 mcg/kg once daily on an empty stomach) for 3 to 5 days.” Caregivers of isolated patients were instructed to “administer hydroxychloroquine prophylaxis as prescribed by the protocol and treating physician.

Of the 292 studies demonstrating the effectiveness of hydroxychloroquine in preventing CCHVs, 219 were peer-reviewed; of the 93 studies demonstrating the effectiveness of ivermectin against CCHVs, 54 were peer-reviewed.

Although lives were saved and although it is now an undisputed fact that both drugs, in a matter of hours or days, kill the CCP virus, the Bill Gates-funded World Health Organization (WHO) and Big Pharma are up in arms about the new Indian guidelines and results.

The use of ivermectin was halted in the state of Tamil Nadu on May 17, when the state health department removed ivermectin from its case management protocol.

WHO’s chief scientist, Indian lady Soumya Swaminathan, tweeted on May 10 that WHO recommended against the use of ivermectin to treat the CCP virus. Swaminathan cited a Merck press release from February that said there was “no scientific basis” for ivermectin to treat and prevent the Chinese Communist virus. Merck, which discovered ivermectin and holds a long-standing patent on it, is one of the largest donors to the CDC Foundation.

Statistical charts show that daily infection figures for the CCP virus in India, at the end of April, dropped sharply

The chart above shows that the number of active cases of CCP virus in India was also dropping sharply at the end of April